- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.02. | Bristol Myers Squibb notches overall survival win with Opdivo in pre-operative NSCLC | ||
| 19.02. | Novartis pumps $7.5M into push to save 100,000 lives from prostate cancer by 2035 | ||
| 19.02. | Stock stagnation prompts a 16% pay cut for AstraZeneca CEO Pascal Soriot despite strong sales sheet | ||
| 18.02. | Bavarian Nordic catches up to rival Valneva with broad chikungunya vaccine approval from FDA | ||
| 18.02. | As BMS-paired triplet misses survival mark in kidney cancer, Exelixis shifts focus elsewhere | ||
| 18.02. | FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog | ||
| 18.02. | ICU Medical recalls potassium chloride IV bags over labeling snafu | ||
| 18.02. | Argenx puts marketing muscle behind CIDP launch with Vyvgart Hytrulo TV campaign | ||
| 14.02. | Inizio Evoke alums flex healthcare marketing prowess with launch of new agency | ||
| 14.02. | Moderna shoulders $238M contract manufacturing cancellation charge in Q4 | ||
| 14.02. | Fierce Pharma Asia-Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase' | ||
| 14.02. | UCB's Bimzelx outpacing AbbVie's Rinvoq, Skyrizi on awareness early in psoriatic arthritis launch: survey | ||
| 14.02. | Bristol Myers Squibb comes up short in bid to expand Opdualag in melanoma | ||
| 13.02. | Moderna trims digital team, lays off employees as chief information officer departs | ||
| 13.02. | Alnylam touts Amvuttra's potential move into ATTR-CM as a 'market-growth story' | ||
| 13.02. | Astellas' eye med Izervay lands key FDA label update, amping up market battle with Apellis rival | ||
| 13.02. | It's official: Senate votes to confirm RFK Jr. as HHS secretary | ||
| 13.02. | Rovi warns analyst profit consensus is too high, cites CDMO slowdown | ||
| 13.02. | CDMO Axplora reveals €50M expansion at French production site | ||
| 12.02. | 'We cannot stay silent': Novo Nordisk flags dangers of compounded GLP-1s following Hims & Hers Super Bowl ad | ||
| 12.02. | Pfizer's blockbuster ADC Adcetris nabs FDA approval to treat large B-cell lymphoma | ||
| 12.02. | Roche nabs FDA nod for Evrysdi tablets, bolstering convenience edge over rivals | ||
| 12.02. | Astellas shifts investment focus to later-stage opportunities amid reprioritization | ||
| 12.02. | AstraZeneca's Alexion creates interactive fantasy storybook to help kids with aHUS understand rare kidney disease | ||
| 12.02. | Seeking fruitful Lenmeldy launch, Orchard names commercial chief to oversee world's most expensive drug |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
